Author(s): Francesca Gay, Lorenzo De Paoli, Alessandra Larocca Abstract: PS1299 Session topic: 14. Myeloma and other monoclonal gammopathies – Clinical Background Lenalidomide maintenance is approved in newly diagnosed multiple myeloma (NDMM) patients (pts) who received high-dose therapy (HDT) and autologous stem cell transplant (ASCT). Aims The primary aim was to compare...
Pro zobrazení tohoto obsahu je třeba být přihlášen.